(OCI) OCI - Ratings and Ratios
Fertilizer, Ammonia, Methanol, Melamine, Diesel Emission Fluid
OCI EPS (Earnings per Share)
OCI Revenue
Description: OCI OCI
OCI NV is a Dutch company operating in the Fertilizers & Agricultural Chemicals sub-industry, with its common stock listed under the ticker symbol OCI. The companys market capitalization stands at approximately 1.58 billion EUR.
The stock has demonstrated relatively stable price movements, with its 20-day Simple Moving Average (SMA) at 7.43 EUR and 50-day SMA at 7.55 EUR, indicating a potential bullish trend given its position above the 200-day SMA of 7.04 EUR. The Average True Range (ATR) is 0.13 EUR, representing a 1.72% daily price fluctuation, suggesting moderate volatility.
From a fundamental analysis perspective, OCI NVs current P/E ratio is not available, likely due to negative earnings, but its forward P/E stands at 62.89, indicating expected earnings growth. The companys Return on Equity (RoE) is -21.80%, signifying negative profitability. Key drivers for the companys performance include global demand for fertilizers, nitrogen prices, and the overall health of the agricultural sector.
To evaluate OCI NVs potential, its essential to monitor KPIs such as revenue growth, gross margin, and cash flow generation. Additionally, industry trends, including the global nitrogen markets dynamics and the impact of environmental regulations on fertilizer production, will be crucial. The companys ability to manage costs, improve profitability, and navigate the cyclical nature of the fertilizers and agricultural chemicals industry will be key to its success.
Economic drivers influencing OCI NV include global food demand, energy prices (as they impact production costs), and geopolitical factors affecting trade and agricultural policies. The companys exposure to these factors, along with its operational efficiency and strategic decisions, will significantly impact its financial performance and stock price.
OCI Stock Overview
| Market Cap in USD | 1,207m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception |
OCI Stock Ratings
| Growth Rating | 36.9% |
| Fundamental | 27.0% |
| Dividend Rating | 75.7% |
| Return 12m vs S&P 500 | 1.06% |
| Analyst Rating | - |
OCI Dividends
| Dividend Yield 12m | 175.24% |
| Yield on Cost 5y | 630.19% |
| Annual Growth 5y | 42.75% |
| Payout Consistency | 73.6% |
| Payout Ratio | 182.3% |
OCI Growth Ratios
| Growth Correlation 3m | 53.9% |
| Growth Correlation 12m | 64.3% |
| Growth Correlation 5y | 66.9% |
| CAGR 5y | -1.21% |
| CAGR/Max DD 3y | -0.03 |
| CAGR/Mean DD 3y | -0.05 |
| Sharpe Ratio 12m | -0.16 |
| Alpha | 11.05 |
| Beta | 0.441 |
| Volatility | 31.44% |
| Current Volume | 538.9k |
| Average Volume 20d | 620.2k |
| Stop Loss | 4.7 (-4.9%) |
| Signal | 0.47 |
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-220.0m TTM) > 0 and > 6% of Revenue (6% = 154.3m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -13.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 77.06% (prev 2.18%; Δ 74.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 553.0m > Net Income -220.0m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (211.1m) change vs 12m ago 0.39% (target <= -2.0% for YES) |
| Gross Margin 8.46% (prev 23.54%; Δ -15.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.94% (prev 77.12%; Δ -49.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.43 (EBITDA TTM -126.5m / Interest Expense TTM 165.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.19
| (A) 0.22 = (Total Current Assets 7.03b - Total Current Liabilities 5.04b) / Total Assets 8.98b |
| (B) -0.35 = Retained Earnings (Balance) -3.11b / Total Assets 8.98b |
| (C) -0.01 = EBIT TTM -71.6m / Avg Total Assets 9.20b |
| (D) -0.44 = Book Value of Equity -3.11b / Total Liabilities 7.10b |
| Total Rating: -0.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 26.98
| 1. Piotroski 1.50pt = -3.50 |
| 2. FCF Yield 1.59% = 0.79 |
| 3. FCF Margin 2.10% = 0.52 |
| 4. Debt/Equity 2.46 = 0.06 |
| 5. Debt/Ebitda -17.90 = -2.50 |
| 6. ROIC - WACC -5.30% = -6.62 |
| 7. RoE -21.80% = -2.50 |
| 8. Rev. Trend -84.11% = -6.31 |
| 9. EPS Trend -59.38% = -2.97 |
What is the price of OCI shares?
Over the past week, the price has changed by +4.04%, over one month by +12.11%, over three months by +8.19% and over the past year by +20.15%.
Is OCI a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OCI is around 15.22 EUR . This means that OCI is currently undervalued and has a potential upside of +208.1% (Margin of Safety).
Is OCI a buy, sell or hold?
What are the forecasts/targets for the OCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.9 | 39.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 16.2 | 227.7% |
OCI Fundamental Data Overview
Market Cap USD = 1.21b (1.03b EUR * 1.1726 EUR.USD)
CCE Cash And Equivalents = 73.7m USD (Cash only, last quarter)
P/E Forward = 30.2115
P/S = 1.0557
P/B = 0.5386
Beta = 0.773
Revenue TTM = 2.57b USD
EBIT TTM = -71.6m USD
EBITDA TTM = -126.5m USD
Long Term Debt = 1.76b USD (from longTermDebt, last quarter)
Short Term Debt = 502.8m USD (from shortLongTermDebt, last quarter)
Debt = 2.26b USD (Calculated: Short Term 502.8m + Long Term 1.76b)
Net Debt = 2.19b USD (from netDebt column, last quarter)
Enterprise Value = 3.40b USD (1.21b + Debt 2.26b - CCE 73.7m)
Interest Coverage Ratio = -0.43 (Ebit TTM -71.6m / Interest Expense TTM 165.0m)
FCF Yield = 1.59% (FCF TTM 53.9m / Enterprise Value 3.40b)
FCF Margin = 2.10% (FCF TTM 53.9m / Revenue TTM 2.57b)
Net Margin = -8.56% (Net Income TTM -220.0m / Revenue TTM 2.57b)
Gross Margin = 8.46% ((Revenue TTM 2.57b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Tobins Q-Ratio = -1.09 (set to none) (Enterprise Value 3.40b / Book Value Of Equity -3.11b)
Interest Expense / Debt = 1.37% (Interest Expense 31.0m / Debt 2.26b)
Taxrate = 21.0% (US default)
NOPAT = -71.6m (EBIT -71.6m, no tax applied on loss)
Current Ratio = 1.39 (Total Current Assets 7.03b / Total Current Liabilities 5.04b)
Debt / Equity = 2.46 (Debt 2.26b / last Quarter total Stockholder Equity 920.4m)
Debt / EBITDA = -17.90 (Net Debt 2.19b / EBITDA -126.5m)
Debt / FCF = 42.01 (Debt 2.26b / FCF TTM 53.9m)
Total Stockholder Equity = 1.01b (last 4 quarters mean)
RoA = -2.45% (Net Income -220.0m, Total Assets 8.98b )
RoE = -21.80% (Net Income TTM -220.0m / Total Stockholder Equity 1.01b)
RoCE = -2.58% (Ebit -71.6m / (Equity 1.01b + L.T.Debt 1.76b))
RoIC = -1.94% (NOPAT -71.6m / Invested Capital 3.70b)
WACC = 3.36% (E(1.21b)/V(3.47b) * Re(7.64%)) + (D(2.26b)/V(3.47b) * Rd(1.37%) * (1-Tc(0.21)))
Shares Correlation 3-Years: -9.23 | Cagr: 0.01%
Discount Rate = 7.64% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.27% ; FCFE base≈565.7m ; Y1≈690.0m ; Y5≈1.15b
Fair Price DCF = 92.64 (DCF Value 19.54b / Shares Outstanding 210.9m; 5y FCF grow 23.49% → 3.0% )
EPS Correlation: -59.38 | EPS CAGR: -44.45% | SUE: 0.0 | # QB: False
Revenue Correlation: -84.11 | Revenue CAGR: -33.78%